Formidable Asset Management’s CytomX Therapeutics CTMX Stock Holding History

Formidable Asset Management’s Portfolio CTMX Stock Details CTMX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$66.4K	Sell	17,710 -553	-3%	-$2.11K	0.01%	383
2026 Q1	$85.8K	Sell	18,263 -27,500	-60%	-$140K	0.01%	375
2025 Q4	$195K	Sell	45,763 -72,574	-61%	-$276K	0.03%	386
2025 Q3	$377K	Sell	118,337 -194,513	-62%	-$438K	0.06%	288
2025 Q2	$710K	Sell	312,850 -40,990	-12%	-$66.1K	0.12%	166
2025 Q1	$225K	Sell	353,840 -28,689	-7%	-$22.2K	0.04%	354
2024 Q4	$394K	Buy	382,529 +136,528	+55%	+$147K	0.06%	265
2024 Q3	$290K	Sell	246,001 -12,000	-5%	-$15.2K	0.05%	293
2024 Q2	$315K	Sell	258,001 -30,100	-10%	-$59.9K	0.05%	298
2024 Q1	$628K	Sell	288,101 -18,006	-6%	-$33.2K	0.1%	207
2023 Q4	$474K	Sell	306,107 -12,004	-4%	-$15.8K	0.1%	177
2023 Q3	$410K	Hold	318,111	–	–	0.09%	189
2023 Q2	$547K	Hold	318,111	–	–	0.12%	160
2023 Q1	$480K	Sell	318,111 -122	-0%	-$276	0.1%	180
2022 Q4	$509K	Buy	318,233 +6,918	+2%	+$10.2K	0.12%	161
2022 Q3	$451K	Buy	311,315 +103,543	+50%	+$159K	0.1%	172
2022 Q2	$380K	Buy	+207,772	New	+$398K	0.09%	203

Other funds holding CTMX

Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return

Tema ETFs New York $3.09B AUM 72.72% 1-Year Est. Return

CUAMC

China Universal Asset Management Company Shanghai, China $1.67B AUM 89% 1-Year Est. Return

PAG

Private Advisor Group Morristown, New Jersey $21.8B AUM 28.57% 1-Year Est. Return

MFG

Merit Financial Group Alpharetta, Georgia $16.4B AUM 25.17% 1-Year Est. Return

PFSRSONJ

Police & Firemen's Retirement System of New Jersey Trenton, New Jersey $13.3B AUM 45.46% 1-Year Est. Return

CPC

Congress Park Capital Saratoga Springs, New York $370M AUM 26.01% 1-Year Est. Return

PSP Research Newtown Square, Pennsylvania $188M AUM

WFA

WestHill Financial Advisors San Rafael, California $587M AUM 20.13% 1-Year Est. Return

Whittier Trust South Pasadena, California $10.2B AUM 33.39% 1-Year Est. Return

Formidable Asset Management's CTMX Position: Q2 2026 in Review

Formidable Asset Management reduced its CytomX Therapeutics (CTMX) stake by 3% in Q2 2026, selling an estimated $2.11K and leaving 17,710 shares worth $66.4K. The position accounts for 0.01% of the portfolio, ranked #383.

Formidable Asset Management first reported a position in CTMX in Q2 2022 and has held it in 17 quarters since. The position peaked at $710K in Q2 2025. 17 funds tracked by Wall St. Rank hold CTMX as of Q2 2026.

Formidable Asset Management held 17,710 shares of CytomX Therapeutics worth $66.4K as of Q2 2026.
Formidable Asset Management sold 553 CytomX Therapeutics shares in Q2 2026, an estimated $2.11K.
CytomX Therapeutics made up 0.01% of Formidable Asset Management's portfolio in Q2 2026, its #383 holding.
Formidable Asset Management first reported a position in CytomX Therapeutics in Q2 2022 and has held it in 17 quarters since.
Formidable Asset Management's CytomX Therapeutics position peaked at $710K in Q2 2025.
17 funds tracked by Wall St. Rank held CytomX Therapeutics as of Q2 2026.

Based on Formidable Asset Management's 13F filing for Q2 2026, filed 17 Jul 2026.